Eurofins BioPharma Services Newsletter 17 - June 2017
ARTICLES:
- Changes to EU Medical Device Legislation: What you need to know
- Optimising Cytomegalovirus (CMV) Outcomes with Personalised Testing
- Development and Qualification of a Characterisation Panel to Assess the Biological Activity of Golimumab (Simponi®)
- Eurofins Lancaster Laboratories PSS Insourcing Solutions® expands global reach at record pace
- New solutions for Endocrine Disrupters
Download the PDF version of pharma newsletter N°17
Receive the next newsletter via email